Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
MRMD Stock Summary
Top 10 Correlated ETFs
MRMD
In the News
The 7 Most Undervalued Cannabis Stocks to Buy in December
Given that cannabis legalization is considered a growth trend, you may assume that there are few (if any) undervalued cannabis stocks. However, whether we're talking about undervalued in the traditional sense of the term, or undervalued using other metrics, there are plenty of names in the space that fit within this category.
Top Marijuana Stocks For The 2024 Green Rush
Marijuana stocks are still in a volatile place in the stock market. Yet this has played a part in why they can invest in the future of cannabis at low price points. Right now there is a lack of upward trading consistency for the sector. Meaning that most cannabis stocks can not sustain an upward position in the market. Often when there is a volatile rise in trading it is short-lived only seeing a recovery for just a few minutes even just moments.
Top 3 Marijuana Penny Stocks to Watch Post-Thanksgiving
The United States cannabis industry and top marijuana stocks are witnessing a remarkable expansion. Recent forecasts predict significant growth in the coming years. This surge is fueled by increasing legalization and societal acceptance. As a result, investors are keenly observing marijuana penny stocks. These stocks represent companies in the developing phase of the cannabis sector. They offer unique growth opportunities. However, their low share prices often reflect higher volatility and risk.
Reasons To Be Cautiously Optimistic About Cannabis
Cautious optimism is warranted in the cannabis industry due to potential changes, such as the move to federal legalization and improved fundamentals. Investors should consider their risk appetite, timeframes, and political catalysts when choosing cannabis companies to invest in.
MariMed to Participate in Upcoming Investor Conferences
NORWOOD, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”), (CSE: MRMD), (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, announced its participation in the following upcoming investor conferences:
Top Marijuana Penny Stocks for September 2023
Welcome to the worldwide arena of marijuana stocks in the ever-changing cannabis sector, where the intersection of financial prospects and rising legality is creating a buzz unlike any other. As we approach September 2023, the stage is set for investors to investigate the top marijuana penny stocks with enormous growth potential. Technical analysis is critical in both day trading and swing trading methods in this volatile market, providing traders with vital insights into price movements and trends.
7 Smoking-Hot 420 Stocks to Buy in 2023
Sentiment for the cannabis sector has yet to rebound from its last peak in late 2020/early 2021, but that doesn't mean you need to skip out on 420 stocks. Even Forbes recently argued that full U.S. legalization of marijuana remains (at least) a decade away.
Green Earnings: Cannabis Penny Stocks with Potential Amidst Reporting Season
August 2023 is a good time for individuals interested in the volatile world of marijuana stocks. Because of the growing legality and acceptability of cannabis products, these emerging companies, frequently distinguished by low stock prices, have attracted considerable interest. As investors look for new opportunities, it's critical to identify the top marijuana penny stocks primed for growth in this turbulent but potentially lucrative industry. With creative developments, evolving regulatory landscapes, and shifting customer preferences impacting the sector, discerning investors are directing their attention to companies that demonstrate excellent fundamentals and a strategic understanding of market trends.
Top Marijuana Penny Stocks to Watch in August 2023
Welcome to the intriguing world of marijuana penny stocks! As we approach August 2023, the cannabis sector is witnessing rapid growth and drawing investors looking to cash in on the green revolution. Penny stock trading can be exciting and risky; therefore, it is critical to approach these investments with caution and sound risk management measures.
Unlocking Short-Term Gains: Top Marijuana Stocks Before August 2023
As we approach the midway point of 2023, the cannabis industry continues to garner attention from investors seeking lucrative opportunities. With increasing legalization efforts across the United States and beyond, marijuana stocks are poised for potential growth and profitability.
MRMD Financial details
MRMD Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.22 | 0.16 | 0.34 | 0.35 | 0.41 | |
Net income per share | -0.32 | 0.01 | 0.02 | 0.04 | -0.04 | |
Operating cash flow per share | -0.12 | 0.01 | 0.1 | 0.02 | 0.02 | |
Free cash flow per share | -0.16 | 0 | 0.05 | -0.01 | -0.04 | |
Cash per share | 0.01 | 0.01 | 0.08 | 0.03 | 0.04 | |
Book value per share | 0.03 | 0.03 | 0.1 | 0.15 | 0.2 | |
Tangible book value per share | 0.01 | 0.01 | 0.09 | 0.09 | 0.11 | |
Share holders equity per share | 0.03 | 0.03 | 0.1 | 0.15 | 0.2 | |
Interest debt per share | 0.27 | 0.16 | 0.07 | 0.1 | 0.27 | |
Market cap | 128.61M | 152.36M | 312.48M | 135.44M | 99.86M | |
Enterprise value | 170.58M | 191.97M | 307.16M | 161.56M | 184.34M | |
P/E ratio | -1.93 | 71.06 | 43.25 | 10.06 | -6.23 | |
Price to sales ratio | 2.82 | 2.99 | 2.57 | 1.01 | 0.67 | |
POCF ratio | -5.33 | 45.07 | 8.72 | 18.53 | 12.62 | |
PFCF ratio | -3.77 | -97.51 | 18.07 | -24.94 | -7.77 | |
P/B Ratio | 18.69 | 17.56 | 8.25 | 2.3 | 1.4 | |
PTB ratio | 18.69 | 17.56 | 8.25 | 2.3 | 1.4 | |
EV to sales | 3.74 | 3.77 | 2.53 | 1.21 | 1.24 | |
Enterprise value over EBITDA | -8.48 | 10.75 | 9.62 | 5.28 | 7.79 | |
EV to operating cash flow | -7.07 | 56.79 | 8.57 | 22.1 | 23.31 | |
EV to free cash flow | -5 | -122.86 | 17.77 | -29.75 | -14.35 | |
Earnings yield | -0.52 | 0.01 | 0.02 | 0.1 | -0.16 | |
Free cash flow yield | -0.27 | -0.01 | 0.06 | -0.04 | -0.13 | |
Debt to equity | 6.21 | 4.91 | 0.64 | 0.61 | 1.24 | |
Debt to assets | 0.69 | 0.56 | 0.2 | 0.24 | 0.45 | |
Net debt to EBITDA | -2.09 | 2.22 | -0.17 | 0.85 | 3.57 | |
Current ratio | 0.2 | 0.91 | 1.64 | 1.67 | 1.67 | |
Interest coverage | 0.44 | 1.48 | 11.4 | 12.03 | 1.64 | |
Income quality | 0.29 | 1.39 | 4.7 | 0.54 | -0.49 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | -0.01 | 0.14 | 0.06 | 0.02 | -0.01 | |
Sales general and administrative to revenue | 0.28 | 0.3 | 0.3 | 0.26 | 0.3 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.04 | 0.03 | 0.02 | 0.15 | 0.15 | |
Capex to operating cash flow | 0.41 | -1.46 | -0.52 | -1.74 | -2.62 | |
Capex to revenue | -0.22 | -0.1 | -0.15 | -0.1 | -0.14 | |
Capex to depreciation | -8.34 | -2.27 | -6.66 | -2.7 | -2.42 | |
Stock based compensation to revenue | 0 | 0.02 | 0.1 | 0.05 | 0.01 | |
Graham number | 0.49 | 0.06 | 0.22 | 0.35 | 0.44 | |
ROIC | 0.08 | 0.14 | 0.13 | 0.14 | 0.21 | |
Return on tangible assets | -1.12 | 0.03 | 0.06 | 0.1 | -0.1 | |
Graham Net | -0.24 | -0.17 | -0.14 | -0.18 | -0.25 | |
Working capital | -29.34M | -2.18M | 17.39M | 17.66M | 20.57M | |
Tangible asset value | 3.96M | 5.87M | 34.07M | 35.03M | 40.91M | |
Net current asset value | -47.87M | -47.3M | -42.29M | -50.75M | -74.78M | |
Invested capital | 6.21 | 4.91 | 0.64 | 0.61 | 1.24 | |
Average receivables | 7.58M | 6.53M | 6.37M | 5.5M | 8.26M | |
Average payables | 4.32M | 4.88M | 5.07M | 5.86M | 7.81M | |
Average inventory | 609.71K | 4.03M | 8.3M | 14.62M | 22.39M | |
Days sales outstanding | 30.23 | 66.51 | 10.43 | 20.5 | 22.07 | |
Days payables outstanding | 64.03 | 94.09 | 33.71 | 34.52 | 31.2 | |
Days of inventory on hand | 16.54 | 127.4 | 64.59 | 101.48 | 87.73 | |
Receivables turnover | 12.07 | 5.49 | 35 | 17.8 | 16.54 | |
Payables turnover | 5.7 | 3.88 | 10.83 | 10.57 | 11.7 | |
Inventory turnover | 22.06 | 2.87 | 5.65 | 3.6 | 4.16 | |
ROE | -9.67 | 0.25 | 0.19 | 0.23 | -0.22 | |
Capex per share | -0.05 | -0.02 | -0.05 | -0.03 | -0.06 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.09 | 0.1 | 0.1 | 0.1 | 0.1 | |
Net income per share | 0.01 | 0 | 0 | -0.01 | -0.03 | |
Operating cash flow per share | 0 | -0.01 | 0 | 0.02 | 0.01 | |
Free cash flow per share | 0 | -0.02 | -0.01 | 0.01 | -0.01 | |
Cash per share | 0.03 | 0.06 | 0.04 | 0.04 | 0.04 | |
Book value per share | 0.15 | 0.19 | 0.23 | 0.22 | 0.19 | |
Tangible book value per share | 0.09 | 0.1 | 0.14 | 0.13 | 0.11 | |
Share holders equity per share | 0.15 | 0.19 | 0.23 | 0.22 | 0.19 | |
Interest debt per share | 0.1 | 0.2 | 0.19 | 0.18 | 0.24 | |
Market cap | 136M | 134.55M | 148.12M | 162.5M | 103.33M | |
Enterprise value | 162.12M | 177.93M | 198.95M | 213.24M | 187.81M | |
P/E ratio | 7.16 | -50.66 | -38.65 | -9.54 | -2.54 | |
Price to sales ratio | 3.8 | 3.91 | 4.06 | 4.19 | 2.66 | |
POCF ratio | 78.3 | -29.91 | 116.17 | 20.57 | 31.95 | |
PFCF ratio | -197.39 | -16.5 | -33.22 | 84.99 | -48.13 | |
P/B Ratio | 2.31 | 2.01 | 1.8 | 1.99 | 1.44 | |
PTB ratio | 2.31 | 2.01 | 1.8 | 1.99 | 1.44 | |
EV to sales | 4.52 | 5.18 | 5.45 | 5.5 | 4.83 | |
Enterprise value over EBITDA | 23.36 | 39.72 | 48.34 | 82.49 | 37.46 | |
EV to operating cash flow | 93.33 | -39.55 | 156.04 | 26.99 | 58.07 | |
EV to free cash flow | -235.3 | -21.83 | -44.62 | 111.53 | -87.47 | |
Earnings yield | 0.03 | 0 | -0.01 | -0.03 | -0.1 | |
Free cash flow yield | -0.01 | -0.06 | -0.03 | 0.01 | -0.02 | |
Debt to equity | 0.61 | 0.97 | 0.79 | 0.79 | 1.24 | |
Debt to assets | 0.24 | 0.35 | 0.35 | 0.34 | 0.45 | |
Net debt to EBITDA | 3.76 | 9.68 | 12.35 | 19.63 | 16.85 | |
Current ratio | 1.67 | 2.42 | 1.98 | 1.44 | 1.67 | |
Interest coverage | 13.15 | 1.17 | 1.34 | 1.33 | 1.58 | |
Income quality | 0.37 | 6.78 | -1.36 | -1.85 | -0.32 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.01 | -0.05 | -0.05 | -0.01 | 0 | |
Sales general and administrative to revenue | 0.23 | 0.26 | 0.29 | 0.31 | 0.34 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.15 | 0.17 | 0.16 | 0.16 | 0.15 | |
Capex to operating cash flow | -1.4 | 0.81 | -4.5 | -0.76 | -1.66 | |
Capex to revenue | -0.07 | -0.11 | -0.16 | -0.15 | -0.14 | |
Capex to depreciation | -1.74 | -2.37 | -2.81 | -2.46 | -2.11 | |
Stock based compensation to revenue | 0 | 0.01 | 0.01 | 0.01 | 0.01 | |
Graham number | 0.21 | 0.09 | 0.12 | 0.24 | 0.34 | |
ROIC | 0.09 | -0.01 | -0.02 | -0.46 | 0.02 | |
Return on tangible assets | 0.04 | 0 | -0.01 | -0.03 | -0.06 | |
Graham Net | -0.18 | -0.23 | -0.21 | -0.21 | -0.24 | |
Working capital | 17.66M | 34.87M | 28.69M | 15.5M | 20.57M | |
Tangible asset value | 35.03M | 33.79M | 50.21M | 50.01M | 40.91M | |
Net current asset value | -50.75M | -59.75M | -50.55M | -60.16M | -74.78M | |
Invested capital | 0.61 | 0.97 | 0.79 | 0.79 | 1.24 | |
Average receivables | 7.47M | 7.62M | 8.28M | 8M | 8.06M | |
Average payables | 7.3M | 5.65M | 6.21M | 8.13M | 8.75M | |
Average inventory | 18.89M | 21.1M | 23.75M | 24.5M | 24.76M | |
Days sales outstanding | 18.91 | 20.18 | 21.82 | 16.56 | 20.79 | |
Days payables outstanding | 29.79 | 22.11 | 34.69 | 34.81 | 28.93 | |
Days of inventory on hand | 87.57 | 107.68 | 110.75 | 99.2 | 81.33 | |
Receivables turnover | 4.76 | 4.46 | 4.13 | 5.43 | 4.33 | |
Payables turnover | 3.02 | 4.07 | 2.59 | 2.59 | 3.11 | |
Inventory turnover | 1.03 | 0.84 | 0.81 | 0.91 | 1.11 | |
ROE | 0.08 | -0.01 | -0.01 | -0.05 | -0.14 | |
Capex per share | -0.01 | -0.01 | -0.02 | -0.02 | -0.01 |
MRMD Frequently Asked Questions
What is MariMed Inc. stock symbol ?
MariMed Inc. is a US stock , located in Norwood of Ma and trading under the symbol MRMD
Is MariMed Inc. buy or a sell ?
1 stock analysts have 1 predictions with a medium analyst target price of $2.25. The lowest prediction is $2.25 and the highest is $2.25
What is MRMD stock prediction ?
What is MariMed Inc. stock quote today ?
MariMed Inc. stock price is $0.2725 today.
Is MariMed Inc. stock public?
Yes, MariMed Inc. is a publicly traded company.